Overview
Hirokazu Iso practices in Tokyo, Japan. Iso is rated as an Advanced expert by MediFind in the treatment of Metastatic Pleural Tumor. Their top areas of expertise are Metastatic Pleural Tumor, Febrile Neutropenia, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
Their clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Metastatic Pleural Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Metastatic Pleural Tumor
- Experienced
- AgranulocytosisIso isExperienced. Learn about Agranulocytosis.
- ChoriocarcinomaIso isExperienced. Learn about Choriocarcinoma.
- Chronic Eosinophilic Pneumonia
- EGFR Positive Lung CancerIso isExperienced. Learn about EGFR Positive Lung Cancer.
- Eosinophilic PneumoniaIso isExperienced. Learn about Eosinophilic Pneumonia.
- Febrile NeutropeniaIso isExperienced. Learn about Febrile Neutropenia.